Holen Sie sich die Stockscreener-App
38.65
2.05%
-0.81
Handel nachbörslich:
38.51
-0.14
-0.36%
Schlusskurs vom Vortag:
$39.46
Offen:
$39.53
24-Stunden-Volumen:
3.80M
Relative Volume:
0.93
Marktkapitalisierung:
$16.71B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
16.83
EPS:
2.297
Netto-Cashflow:
$827.02M
1W Leistung:
-2.37%
1M Leistung:
+4.43%
6M Leistung:
+12.85%
1J Leistung:
+48.60%
1-Tages-Spanne:
$37.77
$39.69
1-Wochen-Bereich:
$37.77
$40.01
52-Wochen-Spanne:
$24.05
$41.24
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
38.65 | 16.86B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.76 | 61.08B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Royalty Pharma Insider Sold Shares Worth $2,735,329, According to a Recent SEC Filing - MarketScreener
Why Royalty Pharma plc (RPD) stock could break out in 2025CPI Data & Proven Capital Preservation Methods - newser.com
What macro factors could drive Royalty Pharma plc (RPD) stock higher2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Trading the Move, Not the Narrative: (RPRX) Edition - news.stocktradersdaily.com
Historical volatility pattern of Royalty Pharma plc visualizedJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Is Royalty Pharma plc (RPD) stock attractive post correctionWall Street Watch & Risk Managed Investment Signals - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcJuly 2025 Summary & Verified Technical Signals - newser.com
How Royalty Pharma plc (RPD) stock compares with top peersWeekly Stock Analysis & Safe Capital Investment Plans - newser.com
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessWeekly Market Report & High Accuracy Investment Signals - newser.com
Top chart patterns to watch in Royalty Pharma plcBull Run & Safe Capital Growth Plans - newser.com
Why analysts remain bullish on Royalty Pharma plc stockEntry Point & Low Drawdown Trading Strategies - newser.com
Applying chart zones and confluence areas to Royalty Pharma plcQuarterly Risk Review & Daily Risk Controlled Trade Plans - newser.com
Will Royalty Pharma plc (RPD) stock maintain strong growthMarket Performance Recap & Long-Term Safe Return Strategies - newser.com
Royalty Pharma (RPRX): Is the Stock Undervalued After Higher 2025 Revenue Guidance and Major Buyback Completion? - Yahoo Finance
How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves - Yahoo Finance UK
Vise Technologies Inc. Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
Ontario Teachers Pension Plan Board Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat
Published on: 2025-11-18 06:12:54 - newser.com
Why retail investors pile into Royalty Pharma plc stockJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
Forsta AP Fonden Reduces Stake in Royalty Pharma PLC $RPRX - MarketBeat
Geode Capital Management LLC Has $299.49 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
What indicators show strength in Royalty Pharma plc2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
What analysts say about Royalty Pharma plc stockShort-Term Trading Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
What’s the recovery path for long term holders of Royalty Pharma plc - newser.com
What MACD signals say about Royalty Pharma plcTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat
Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Rally & Free Safe Capital Growth Stock Tips - newser.com
Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Quantitative breakdown of Royalty Pharma plc recent moveMarket Growth Report & Reliable Trade Execution Plans - newser.com
Is Royalty Pharma Plc's (NASDAQ:RPRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛
Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated (NASDAQ:RPRX) - Seeking Alpha
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Royalty Pharma Plc-Aktie (RPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Norden Gregory | Director |
Aug 11 '25 |
Sale |
36.23 |
33,500 |
1,213,749 |
194,848 |
0.82%
2.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):